Skip to main
OMDA

OMDA Stock Forecast & Price Target

OMDA Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 33%
Buy 50%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Omada Health is a leader in the virtual healthcare industry, with a comprehensive platform that addresses chronic health conditions and generates cost savings for their partners. Their strong partnerships and proven results make them a promising investment, but potential risks from reliance on virtual services should be carefully monitored. With increased revenue guidance and continued growth, OMDA has a positive outlook for the future.

Bears say

Omada Health is growing quickly and has reached a significant milestone of over 1 million members, but its enormous reliance on just two main partners-Cigna affiliates, and Express Scripts- is concerning. Furthermore, failure to deliver significant outcomes to customers could negatively impact future revenues and put pressure on OMDA's current valuation, which is already trading at a premium compared to its peers in the digital health space. The company's strong balance sheet and efforts in engaging members through its specialized care tracks show potential, but limited pricing power and customer concentration pose a risk to future growth.

OMDA has been analyzed by 12 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 50% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omada Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omada Health Inc (OMDA) Forecast

Analysts have given OMDA a Buy based on their latest research and market trends.

According to 12 analysts, OMDA has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $24.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $24.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omada Health Inc (OMDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.